The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities-Reference-Cited by-同舟云学术

The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities

Published:2009-08-18 Issue:22 Volume:115 Page:5202-5209
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kantarjian Hagop,O'Brien Susan,Ravandi Farhad,Borthakur Gautam,Faderl Stefan,Bueso-Ramos Carlos,Abruzzo Lynne,Pierce Sherry,Shan Jianqin,Issa Jean-Pierre,Garcia-Manero Guillermo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Heamatol,1982

2. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia: November 1977;Harris;J Clin Oncol.,1999

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original international prognostic scoring system;Kantarjian;Cancer,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults;Cancers;2024-02-29

2. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH);Current Research in Translational Medicine;2023-10

3. MDS mit Deletion 5q;Therapeutische Umschau;2022-03

4. Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter?;Expert Review of Hematology;2020-02-20

5. Genetic abnormalities and pathophysiology of MDS;International Journal of Clinical Oncology;2019-05-15